Cellular sensing of L-amino acids is widespread and controls diverse cellular responses regulating, for example, rates of hormone secretion, amino acid uptake, protein synthesis and protein degradation (autophagy). However, the nature of the sensing mechanisms involved has been elusive. One important sensing mechanism is selective for branched chain amino acids, acts via mTOR (mammalian target of rapamycin) and regulates the rates of insulin and IGF-1 secretion as well as hepatic, and possibly muscle, autophagy. A second sensing mechanism is selective for aromatic L-amino acids and regulates the rate of gastric acid secretion and other responses in the gastro-intestinal tract. Interactions between calcium and protein metabolism, including accelerated urinary calcium excretion in subjects consuming high-protein diets and secondary hyperparathyroidism in subjects consuming low-protein diets, suggest an additional amino acid sensing mechanism linked to the control of urinary calcium excretion and parathyroid hormone (PTH) release.
Free L-amino acids are essential molecules in biological systems. This derives, in part, from their fundamental role as the building blocks of proteins, the chief species encoded by DNA. Amino acids are also the metabolic precursors of important biologically active substances that act as the ligands for receptors. These include histamine from L-histidine, 5-hydroxytryptamine (serotonin) from L-tryptophan, and dopamine, catecholamines and thyroid hormone from L-tyrosine. Clearly, cellular amino acid uptake mechanisms are critical for the processes of protein synthesis and amino acid metabolism but how are these processes regulated? Furthermore, to what extent do amino acid sensing mechanisms regulate and coordinate whole body metabolism?
It is now clear that amino acid sensors are widely distributed. For example, an amino acid-sensing mechanism couples elevations in branched chain amino acids such as leucine and isoleucine to stimulation of insulin secretion from pancreatic B cells. Branched chain, and other amino acids, also suppress hepatic autophagy, the process by which amino acids are released by activated lysosomal protein degradation at times of amino acid starvation. Although the identities of these amino acid sensors are unclear, similar intracellular signalling pathways are activated that include stimulation of mTOR (mammalian target of rapamycin) a protein kinase that is a key upstream regulator of the translation initiation apparatus (for review see Van Sluijters et al, 2000) . Amino acid sensing mechanisms, especially for aromatic L-amino acids, also have a significant impact on digestion and absorption by the digestive tract. Finally, an amino acid sensing mechanism would appear to explain how protein and calcium metabolism are linked so that high protein intake promotes urinary calcium excretion (Allen et al, 1979; Johnson et al, 1970; Kerstetter & Allen, 1994 ; Figure 1 ) and low protein intake induces a state of secondary hyperparathyroidism (Kerstetter et al, 1997; Kerstetter et al, 2000b ; Figure 2 ).
Thus, cellular amino acid sensing is widespread, perhaps universal, and permits amino acid-dependent control of cellular signal transduction pathways. As a result, changes in plasma amino acid levels can regulate the rates of protein degradation in muscle and liver as well as the rates of hormone synthesis and secretion from endocrine glands and the regulation of calcium metabolism among other processes. As a consequence, fluctuating plasma levels of amino acids have a major impact on whole body protein, carbohydrate and calcium metabolism and perhaps tissue growth and development.
Role of amino acids in the control of digestion and nutrient disposition Digestion Optimal digestion requires an ability to sense nutrients, activate appropriate gastrointestinal secretory and motor responses and match the rates of these responses to the size of the nutrient load. The gastric phase of protein digestion, for example, requires the release of gastric acid together with the acid-dependent activation of pepsin from its precursor, pepsinogen. Pepsin acts on proteins to release peptides in which aromatic amino acids are exposed at the Cterminus. In addition, some free L-amino acids, especially of the aromatic amino acid group, are also released. Instillation of free amino acids, especially aromatic L-amino acids, into the human stomach promotes gastrin release and gastric acid production (Taylor et al, 1982) . Furthermore, intravenous infusion of amino acids sufficient to elevate total serum Lamino acid levels by 50 -100% -emulating the rise observed after a protein-containing meal -stimulates gastric acid production without activating gastrin release (Isenberg & Maxwell, 1978; Konturek et al, 1978; McArthur et al, 1983) . These effects suggest a simple molecular mechanism whereby sensors for L-amino acids on the luminal membrane of gastrin-releasing cells and the basolateral membrane of gastric acid-secreting parietal cells couple an elevated concentration of free amino acids in the gastric lumen (and the blood) to an accelerated digestive response. The identities of the amino acid sensors, however, and their molecular mechanism of action have remained largely unknown.
Nutrient disposition
It is well known that branched chain amino acids such as leucine, as well as the positively charged amino acid arginine, promote the secretion of insulin from pancreatic beta Figure 1 High dietary protein intake stimulates urinary calcium excretion. Healthy young women were admitted to a hospital metabolic ward and placed on one of three diets that varied according to protein intake but not calcium, phosphate, or total caloric intake. The daily level of dietary protein intake was as indicated in the key. The data (means AE s.e.m.) have been redrawn from Kerstetter et al (1997) with the assistance of the authors. Figure 2 Low dietary protein intake induces elevated parathyroid hormone levels. Healthy young women were admitted to a hospital metabolic ward and placed on one of three diets that varied according to protein intake but not calcium, phosphate, or total caloric intake. The daily level of dietary protein intake was as indicated in the key. The data (means AE s.e.m.) have been redrawn from Kerstetter et al (1997) with the assistance of the authors.
L-Amino acid sensing AD Conigrave et al cells (Wollheim & Biden, 1986) . Absorbed amino acids also appear to suppress the hepatic production of insulin-like growth factor binding protein-1 (IGFBP-1) thereby elevating free levels of the key growth regulator IGF-1 (for review see Fafournoux et al, 2000) . The nature of the amino acid sensors of islet B cells and hepatocytes is still uncertain. Elevated plasma levels of insulin and IGF-1, in turn, promote amino acid accumulation by target tissues -especially muscle (Bonadonna et al, 1993) -and suppress autophagic protein breakdown (for review see Van Sluijters et al, 2000) . Thus, elevated plasma amino acid levels promote amino acid uptake and the cellular protein content via stimulation of insulin and IGF-1 and suppression of protein breakdown.
Role of L-amino acids in cell growth and differentiation
In general, L-amino acids are viewed as passive biological building blocks -to be accumulated intracellularly via the action of specific transporters and then incorporated into proteins upon demand from mRNA-loaded ribosomes. However, the widespread expression of L-amino acid sensors and their coupling to powerful intracellular signalling pathways indicates that the concentrations of amino acids in the extracellular fluid can also regulate the cellular response, eg controlling rates of transcription and translation via activation or inhibition of specific signalling pathways. Thus, the level of protein ingestion and the amino acid composition of the ingested protein may influence developmental outcomes in two quite different ways: firstly as a result of variations in protein synthesis, and secondly by regulating the activities of key signalling pathways that control growth rates and cellular differentiation.
Recent evidence suggests, for example, that dietary protein intake has a positive impact on bone mass and bone mineral density -a key determinant of resistance to osteoporotic fractures (Bonjour et al, 1997; Kerstetter et al, 2000a) . This effect may arise, at least in part, from elevated circulating levels of IGF-1 (Bonjour et al, 1997) , although it seems probable that other molecular mechanisms are also involved. Thus, dietary protein intake may promote bone formation via effects on growth-associated signal transduction pathways as well as enhanced availability of amino acids for protein synthesis.
Interactions between protein and calcium metabolism
Protein and calcium represent two key components of all tissues. Collagen and calcium hydroxyapatite are, of course, the two key structural components of bone. Optimal bone production demands that the rate of mineral deposition should be matched to the rate of matrix, chiefly collagen, synthesis. This consideration seems to imply a local control mechanism in bone whereby rates of protein synthesis and calcium deposition are matched. In fact, a substantial body of evidence indicates that dietary protein intake has a major impact not only on bone mineral metabolism but also on whole body calcium metabolism. Thus, studies on normal healthy young human subjects have revealed that dietary protein intake promotes calcium absorption independent of 1,25 dihydroxyvitamin D (Kerstetter et al, 1998) . In addition, dietary protein intake promotes urinary calcium excretion (Allen et al, 1979; Johnson et al, 1970; Kerstetter & Allen, 1990; Sherman, 1920;  Figure 1 ). Conversely, dietary protein restriction induces sustained elevations in the serum levels of the calciotropic hormone, parathyroid hormone (PTH; Kerstetter et al; 1997; Figure 2 ), an effect that has the potential to degrade bone.
Protein intake and secondary hyperparathyroidism in chronic renal failure Dietary protein intake in many chronic renal failure patients was restricted in the past on the basis that protein breakdown results in the generation of ammonium ions and other toxic nitrogen-containing metabolites whose urinary excretion is impaired in chronic renal failure. Furthermore, high levels of dietary protein intake are frequently accompanied by high levels of inorganic phosphate ingestion resulting in hyperphosphatemia, promoting, in turn, metastatic calcification, hypocalcaemia and secondary hyperparathyroidism. Interestingly, secondary hyperparathyroidism in chronic renal failure responds to dietary supplementation with amino acids and their a-keto acid derivatives (Lindenau et al, 1986) , suggesting a direct molecular link between low dietary protein intake, reduced amino acid levels and secondary hyperparathyroidism. As indicated above, protein restriction also induces secondary hyperparathyroidism in normal subjects -in a fashion unrelated to the serum ionized Ca 2þ concentration (Kerstetter et al, 1997) . How might protein intake and L-amino acids derived from ingested protein influence calcium homeostasis? Ca 2þ -sensing receptors (CaRs) play a major physiological role in the control of PTH secretion and renal calcium excretion and are also expressed in the small intestine (for reviews see Brown & MacLeod, 2001; Conigrave et al, 2000a) . Amino acid modulation of the CaR offers one potential explanation for the links between dietary protein intake and calcium metabolism that have been demonstrated in normal individuals as well as patients with chronic renal failure.
The calcium-sensing receptor
The CaR is a seven transmembrane domain receptor ( Figure  3 ). These receptors are sometimes referred to as 'serpentine' because they 'snake' through the membrane seven times and exhibit an N-terminal 'head' which projects into the extracellular fluid and a C-terminal tail located in the cytoplasm. Members of this class of receptor activate one or more heterotrimeric G-proteins. The CaR plays a key role in L-Amino acid sensing AD Conigrave et al whole body calcium homeostasis and metabolism. Its expression on parathyroid cells provides the sensing mechanism for the feedback regulation of parathyroid hormone secretion ( Figure 4 ) and its expression on thyroid parafollicular C cells is likely to provide the sensing mechanism for the feedback regulation of calcitonin secretion (for review see Brown & MacLeod, 2001) . It also provides a mechanism whereby elevated plasma Ca 2þ levels promote renal calcium excretion independent of changes in PTH levels (Figure 4 ). Its expression in bone including osteoclasts and probably osteoblasts (for review see Brown & MacLeod, 2001 ) implies a role in the control of bone mineral balance. However, its widespread expression, throughout the body, implies expanded biological roles that are unrelated to its major role in calcium homeostasis. Thus, the CaR is also expressed in the brain (in nerve and glial cells; Chattopadhyay et al, 1997 Chattopadhyay et al, , 1998b Ruat et al, 1995) , skin (Bikle et al, 1996; Oda et al, 1998) , the gastrointestinal tract including the stomach (Cheng et al, 1998; Ray et al, 1997; Rutten et al, 1999) , small and large intestine (Chattopadhyay et al, 1998a; Gama et al, 1997) , pancreas (Bruce et al, 1999) and liver (Canaff et al, 2001) as well as the placenta (Bradbury et al, 1998; Kovacs et al, 1998) , and bone marrow (House et al, 1997) .
In molecular terms, the CaR is now recognised as a member of subfamily C of the superfamily of G-proteincoupled receptors. This family includes the metabotropic glutamate receptors (mGluRs), the GABA(B) receptor and a number of pheromone receptors. Receptors of this family are distinguished in structural terms by the massive sizes of their N-terminal heads (approximately 600 amino acids). The size of the CaR head is particularly surprising given that the physiological ligand for the receptor is a small inorganic cation, Ca 2þ . Furthermore, the CaR and mGluR heads share homology with bacterial periplasmic binding proteins (Brauner-Osborne et al, 1999; O'Hara et al, 1993) , which act as Figure 3) . Thus, the CaR appears to be a structural hybrid in evolutionary terms: a primitive nutrient sensor ligated to the N-terminus of a G-protein coupled receptor transducing domain. Does the CaR respond to nutrients other than Ca 2þ ? Is the CaR an amino acid sensor? Does amino acid regulation of the CaR explain the fundamental interactions previously identified between protein and calcium metabolism?
The CaR as a target for L-amino acids
Recent experiments on the cloned human CaR stably expressed in HEK-293 cells (Conigrave et al, 2000b) or transiently expressed in CHO-K1 cells (Conigrave et al, 2000a) have confirmed that the CaR is a molecular target for Lamino acids (Figure 5 and 6) . These data provide a molecular explanation for the link between dietary protein intake and whole body calcium metabolism. In CaR-expressing cells, amino acids were inactive at subthreshold levels of Ca 2þ ions (below about 1.0 mM in HEK-293 cells). However, in the presence of submaximal concentrations of Ca 2þ or other cationic CaR agonists, amino acids activated the CaR as indicated by intracellular Ca 2þ mobilization. The effect was stereo-selective, favouring the natural L-isomer, indicating the existence of a specific amino acid binding site on the receptor protein. Furthermore, the CaR exhibited a preference for aromatic and aliphatic amino acids rather than positively charged or branched chain amino acids, which were inactive. This selectivity is similar to that of the amino acid sensor on gastrin-secreting G-cells and acid-secreting parietal cells in the stomach, but is distinct from that exhibited by pancreatic B cells, hepatocytes and muscle cells which respond preferentially to branched chain amino acids.
The CaR as a molecular target for amino acids in various tissues
Stomach Gastric acid secretion is activated by CaRs that promote the release of gastrin from antral G cells (Ray et al, 1997) as well as CaRs on acid-secreting parietal cells (Geibel et al, 2001) . Furthermore, the CaR, similar to the phenomenon of amino acid-activated gastric acid secretion, is preferentially activated by aromatic L-amino acids such as L-Phe and L-Trp. These findings implicate the CaR as the amino acid sensor for gastric acid secretion. What is the physiological activator of the CaR in this process -Ca 2þ ions, amino acids or both? Dietary protein ingestion is frequently accompanied by dietary calcium. This reflects a basic relationship between protein and calcium as major constituents of cellular tissues. In skeletal muscle cells, for example, the cytoplasm is packed with the contractile proteins myosin and actin and the sarcoplasmic reticulum contains high (ie millimolar) levels of calcium. As a consequence, Ca 2þ and amino acids released within the gastro-intestinal lumen from partially digested animal or plant tissues may act as co-agonists of the CaR. Figure 5 The calcium-sensing receptor exhibits enhanced Ca 2þ sensitivity in the presence of L-amino acids. The figure shows the pharmacological effect of increasing concentrations of L-Phe from 0 to 100 mM. Redrawn from Conigrave et al, (2000b) . Similar data were obtained with other aromatic and aliphatic L-amino acids and with plasma-like amino acid mixtures but not with branched chain amino acids or positively charged amino acids. 
Kidney
The CaR is expressed at multiple sites in the kidney. These include the brush-border of the renal proximal tubule where its functional significance is currently unclear but presumed to participate in the regulation of transepithelial transport (Riccardi et al, 2000) . Other sites of CaR expression in the kidney include the baso-lateral membrane of the cortical thick ascending limb (CTAL), where activated CaRs promote urinary calcium excretion by suppressing Ca 2þ reabsorption (for review see Brown & Hebert, 1996) , and the apical (luminal) membrane of the collecting ducts where activated CaRs suppress vasopressin-induced water reabsorption (Sands et al, 1997) . Amino acids are not normally present in the luminal fluid in the renal collecting ducts so that plasma amino acid levels are unlikely to be involved in the control of urinary osmolality. However, plasma amino acids have ready access to the basolateral (blood-facing) membrane of the CTAL. Thus, allosteric activation of CaRs on the basolateral membrane of the CTAL by amino acids would appear to explain the long-established link between high dietary protein intake and elevated calcium excretion (Allen et al, 1979; Johnson et al, 1970; Sherman, 1920) .
Is the CaR a target for the toxicity of aromatic L-amino acids in the CNS?
In general, amino acids are present at much lower concentrations in the extracellular fluid of the brain than in tissues that lack capillaries with specialized tight junctions of the type responsible for the blood -brain barrier. Thus, the brain is protected from inappropriately elevated levels of amino acids such as glutamate which participate directly in neurotransmission. Thus, CaRs are unlikely to be regulated by Lamino acids in the central nervous system (CNS) under normal conditions. Might the CaR act as a CNS target in the context of pathologically elevated levels of amino acids?
Aromatic L-amino acids are toxic to the brain, eg in hepatic encephalopathy and phenylketonuria. Thus, elevated levels of L-phenylalanine in phenylketonuria interfere with normal myelination resulting in CNS leukodystrophy and mental retardation that is largely prevented by restricting dietary phenylalanine intake from birth. The mechanism by which L-Phe induces these toxic effects is not understood but is thought to arise 'directly' from the exposure of oligodendrocytes, the myelin synthesizing cells, to elevated levels of L-Phe (Levy, 1999) . The problem seems to reduce to the following questions. What is L-Phe's molecular target and how does exposure of this target to L-Phe result in suppressed myelin production and failure of normal CNS maturation? Cells can accumulate hydrophobic amino acids such as L-Phe and L-Leu via the L-type amino acid transporter. However, it is not clear how elevated intracellular levels of phenylalanine exert toxicity or why this toxicity should be selective for oligodendrocytes. Interestingly, the CaR is expressed by oligodendrocytes (Chattopadhyay et al, 1998b) and the level of its expression appears to be maximal at the time of myelination (Ferry et al, 2000) . Thus, the CaR represents a novel CNS target for aromatic L-amino acids such as L-Phe. The CaR might normally participate in the process that couples myelination to neuronal activity via detecting and responding to fluctuating levels of extracellular Ca 2þ in the local vicinity of synapses. Does L-Phe interfere with the coupling process in phenylketonuria by inappropriately activating the CaR? Is there a link between the circadian rhythms for amino acids and parathyroid hormone in plasma? Parathyroid hormone (PTH) exhibits a highly reproducible circadian rhythm in humans with a major peak at about 03:00 h which is as much as 70% above the minimum level that occurs in the late morning (Fraser et al, 1994; Jurbiz et al, 1972) . Repetitive exposure to this transient daily peak of PTH could conceivably promote bone formation via the activation of osteoblasts in a manner comparable to that described for daily subcutaneous injections of PTH (Hodsman et al, 1993) . The origin of the circadian rhythm for PTH, however, is not clear. It is not driven by changes in serum ionized Ca 2þ concentration which exhibits one or more troughs during the afternoon but is largely stable between midnight and 06:00 h (Calvo et al, 1991; Markowitz et al, 1988) . Nevertheless, the diet exerts a considerable influence because the circadian rhythm for PTH is abolished by fasting over several days (Fraser et al, 1994) . One possible dietary factor is inorganic phosphate which exhibits a circadian rhythm in plasma that mimics the rhythm for PTH (Calvo et al, 1991; Markowitz et al, 1988) . Might variations in plasma amino acid level contribute to the circadian rhythm for PTH by altering the Ca 2þ set-point for the CaR? Plasma amino acid levels also exhibit a highly reproducible circadian rhythm (Feigin et al, 1967; Wurtman et al., 1968) . Interestingly, the plasma amino acid level reaches a nadir at about 02:00 -04:00 h in individuals on a normal protein diet. Thus, the trough of the amino acid rhythm coincides with the peak of the PTH rhythm -the predicted behaviour for an acute inhibitor of PTH secretion (Figure 7) . The circadian rhythm for plasma amino acids appears to be exaggerated in individuals on high protein diets but is attenuated in individuals on low protein diets (Fernstrom et al, 1979 ) -a circumstance in which PTH levels are mark-L-Amino acid sensing AD Conigrave et al edly elevated (Kerstetter et al, 1997 (Kerstetter et al, , 2000b 
Other tissues

Concluding remarks
It is now well recognized that amino acids are signalling molecules in their own right that contribute to the regulation of whole body metabolism. The role of amino acids in the control of whole body protein metabolism at the level of islet B cells, hepatocytes and skeletal muscle cells is logical and the molecular mechanisms involved in this aspect of amino acid sensing are currently the subject of active research.
The appreciation that amino acids also provide a signal that connects protein and calcium metabolism is less obvious but explains the results of dietary studies in humans that have a history stretching back 80 y. That one receptor, the calcium-sensing receptor (CaR), makes a major contribution to the link between protein and calcium metabolism is, perhaps, a surprise but is consistent with what is known about the molecular structure and evolutionary origin of this receptor. The data demand a re-evaluation of calcium metabolism in the context of whole body protein metabolism. They also demand a re-evaluation of the role of amino acids in the regulation of the CaR in tissues involved in calcium homeostasis as well as a re-evaluation of the role of the CaR in the gut, brain, skin and other tissues. Is the CaR a primary amino acid sensor at some of these sites?
Many questions are currently unanswered. The following seems particularly important -why should branched chain amino acids such as leucine be used to regulate insulin secretion and protein metabolism in muscle and liver whereas aromatic and aliphatic amino acids are used to regulate the CaR? Figure 7 Circadian rhythms for parathyroid hormone (PTH) and Lamino acids in plasma. (A) Circadian rhythm for intact PTH indicating the position of a highly reproducible peak at around 02:00 -04:00 h. The data (means AE s.e.m.) have been redrawn from Fraser et al (1994) . (B) Circadian rhythm for amino acids in plasma indicating the location of a highly reproducible nadir around 02:00 -04:00 h. The data, expressed as a percentage of the maximum integrated amino acid level, have been redrawn from Feigin et al (1967) . This circadian rhythm is particularly pronounced for the aromatic amino acids L-Phe, L-Trp and L-Tyr 1968) , all CaR activators.
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